Reuters logo
3 个月前
BRIEF-Axim says partner Quay Pharma secures permit to continue development of MedChew
2017年5月2日 / 下午1点18分 / 3 个月前

BRIEF-Axim says partner Quay Pharma secures permit to continue development of MedChew

1 分钟阅读

May 2 (Reuters) - Axim Biotechnologies Inc

* Axim biotechnologies says partner Quay Pharma obtained licenses to import, work with controlled drugs required to continue development of co's MedChew Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below